I am excited to see this proposal from WHO to establish a WHO Model List of Essential In Vitro Diagnostics (EDL), submitted to the next Expert Committee meeting for comments and recommendations about the relevance, scope and the best course of action for developing the list, building on the Essential Medicines List experience.
You may be aware of a series of journal articles, op-eds, and open letters on the need to create an EDL:
The Conversation: https://theconversation.com/africa-has-an-essential-medicines-list-now-it-nee...
Letter to WHO from GHTC: http://www.ghtcoalition.org/pdf/GHTC-letter-World-Health-Organization-essenti...
What are you thoughts on the WHO proposal? Can we provide helpful comments to WHO on this process?
All comments on this forum can be collated and shared with the WHO team working on EDL. I am happy to do that.
Prof Madhukar Pai, MD, PhD
Canada Research Chair in Epidemiology & Global Health
Director, McGill Global Health Programs
Associate Director, McGill International TB Centre